心力衰竭患者在虚拟现实动员中的经验:混合方法研究
Larissa Gussatschenko Caballero1, Iasmin Borges Fraga2, Carlos Eduardo Maciel Tremea3
1Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Programa de Pós-Graduação em Enfermagem, Porto Alegre, RS, Brazil.
Revista da Escola de Enfermagem da U S P
|September 16, 2025
概括
早期动员与虚拟现实 (VR) 结合,显著改善了心力衰竭恢复中的患者体验. 与单独动员相比,这种方法增强了心理效应和身体表现.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 康复科学 康复科学 康复科学
背景情况:
- 急性减补性心力衰竭 (ADHF) 通常需要进入重症监护室 (ICU).
- 早期动员对于患者的康复至关重要,但可能具有挑战性.
- 沉浸式虚拟现实 (VR) 为治疗干预提供了一个新的辅助工具.
研究的目的:
- 为了比较患者早期动员与沉浸式VR相结合的早期动员与单独早期动员的体验.
- 评估VR辅助早期动员对ADHF患者心理和身体结果的影响.
主要方法:
- 一项复杂的混合方法研究,涉及ADHF的成年ICU患者.
- 干预组 (IG) 接受了沉浸式VR的早期动员;控制组 (CG) 仅接受了早期动员.
- 患者的体验被评估使用净促销者得分 (NPS),利克特度量表和定性访谈.
主要成果:
- 这项研究包括60名患者 (73.3%是男性,平均年龄为59.7).
- 93.3%的IG和83.7%的CG报告了良好的或很好的动员经验.
- 定性分析确定了"心理效应"",身体表现"和"创新"作为关键主题.
结论:
- 将VR与早期动员相结合,提供了更积极的患者体验.
- 在重症康复期间,VR可能会提高心理健康和感知到的身体表现.
- 进一步的研究可以探索VR在重症监护康复中的作用.
相关概念视频
Heart Failure I: Introduction
710
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Heart Failure III: Clinical Manifestations
511
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
511
Heart Failure VII: Nursing Interventions
422
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734


